NanoRepro AG

  • WKN: 657710
  • ISIN: DE0006577109
  • Land: Deutschland

Nachricht vom 14.11.2017 | 17:27

DGAP-DD: NanoRepro AG english


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

14.11.2017 / 17:26
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Olaf
Last name(s): Stiller

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
NanoRepro AG

b) LEI
3912008FCA63AGIMEV74 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE0006577109

b) Nature of the transaction
Loan of 95,000 shares of NanoRepro AG. The borrower receives the shares based upon a securities trade agreement free of charge.

c) Price(s) and volume(s)
Price(s) Volume(s)
0.00 EUR 0.00 EUR

d) Aggregated information
Price Aggregated volume
0.00 EUR 0.00 EUR

e) Date of the transaction
2017-11-10; UTC+1

f) Place of the transaction
Outside a trading venue



14.11.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

News im Fokus

Commerzbank baut Privatkundenberatung zu ETFs aus

19. Januar 2018, 14:10

Aktuelle Research-Studie

Sanochemia Pharmazeutika AG

Original-Research: Sanochemia Pharmazeutika AG (von Sphene Capital GmbH): Buy

19. Januar 2018